Published on
The conference is held under the patronage of H.E. Sheikh Nahyan bin Mubarak Al Nahyan and in collaboration with the Department of Health – Abu Dhabi (DOH).
Published on
On June 28, 2022, CHOP welcomed Her Excellency Amna Binzaal Almheiri, Consul General of the United Arab Emirates (UAE) in New York, to observe the world-class experience her country’s patients receive at CHOP. The visit celebrated a long-standing relationship between CHOP and the UAE to improve pediatric care.
Published on
International collaboration aims to ensure more equitable access to transformative personalized cancer therapy.
Published on
International observerships, which were halted by the COVID-19 pandemic, officially resumed at Children’s Hospital of Philadelphia in July 2021 when we welcomed 11 healthcare professionals to our program.
Published on
The CHOP Global Health Center, in collaboration with the Penn Center for Global Health, Penn Nursing, Temple University, and St. Christopher's Hospital for Children, hosted, "Making Up for Lost Time: Addressing Children's Needs Post-Pandemic." The conference brought together global child health experts in person for the first time in two years.
Published on
Children’s Hospital of Philadelphia and The Ministry of Health of Panama (MINSA) have entered into a letter of agreement to explore mutual intent for educational collaborations. The relationship, announced last week, will enhance clinical knowledge and skills that will lead to improved health outcomes for pediatric patients in Panama.
Published on
Thanks to a recent initiative at CHOP, patients newly diagnosed with B-cell and T-cell ALL, and lymphoblastic lymphoma, now go home on average 9 days after diagnosis — that's 3 weeks sooner than previous stays.
Published on
Physicians who see patients with mitochondrial disease have a practical new tool: the first published care standards to guide clinical care.
Published on
This is a game changer for the treatment of pediatric patients battling leukemia and a pivotal milestone in this new era of cellular therapies that treat cancer with a patient’s own immune system.
Published on
Five years after her T-cell therapy for ALL, Emily remains cancer-free. CHOP has since treated more than 170 patients in clinical trials that have seen a 93% remission rate.